Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 1 pseudogene 37 (HMGB1P37) is annotated as a human pseudogene—a non-protein-coding genomic sequence related by homology to the functional High mobility group box 1 gene (HMGB1). While some pseudogenes in the human genome regulate their parent genes through non-coding RNA mechanisms, there is currently no published data indicating that HMGB1P37 has any biological activity or disease association. It is best described as a non-functional vestige or genomic relic[2]. Most databases (HGNC, GeneCards) list HMGB1P37 purely as a pseudogene, with no druggability, signaling, or biomarker attributes[2]. The scientific accuracy of using HMGB1P37 as a therapeutic target is not supported; therefore, this name should not be included in structured lists of actionable drug targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 1 pseudogene 37 (HMGB1P37).